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clear, predictable, and irreversible criteria, which can be used as 
a substitute for a more severe experimental outcome such as ex-
treme suffering or death. Systematic implementation of humane 
endpoints can prevent or reduce pain and/or suffering whilst still 
meeting experimental objectives (Nemzek et al., 2004). 
Thus, application of humane endpoints is a key component of 
refining studies to comply with 3R principles. In models of acute 
disease, death may occur within hours following an experimental 
intervention, which requires both intensive follow-up and consis-
1  Introduction
In experimental mouse studies an important challenge for re-
searchers is to identify an endpoint by which the experiment shall 
be terminated in order to minimize unnecessary suffering of ani-
mals without compromising the quality of the experimental data. 
To systematically address this challenge, the concept of humane 
endpoints was introduced almost 20 years ago in Europe (OECD, 
2000). The application of humane endpoints describes the use of 
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Abstract
Ideally, humane endpoints allow early termination of experiments by minimizing an animal’s discomfort, distress and 
pain while ensuring that scientific objectives are reached. Yet, lack of commonly agreed methodology and heterogeneity 
of cut-off values published in the literature remain a challenge to the accurate determination and application of humane 
endpoints.
With the aim to synthesize and appraise existing humane endpoint definitions for commonly used physiological param-
eters, we conducted a systematic review of mouse studies of acute and chronic disease models that used body weight, 
temperature and/or sickness scores for endpoint definition. We searched for studies in two electronic databases 
(MEDLINE/Pubmed and Embase). Out of 110 retrieved full-text manuscripts, 34 studies were included. We found large 
intra- and inter-model variance in humane endpoint determination and application due to varying animal models, lack of 
standardized experimental protocols, and heterogeneity of performance metrics (part 1).
We then used previously published and unpublished data on weight, temperature, and sickness scores from mouse 
models of sepsis and stroke and applied machine learning models to assess the usefulness of this method for parameter 
selection and endpoint definition across models. Machine learning models trained with physiological data and sickness 
severity score or modified DeSimoni neuroscore identified animals with a high risk of death at an early time point in both 
mouse models of stroke (male: 93.2% at 72 h post-treatment; female: 93.0% at 48 h post-treatment) and sepsis (96.2% at 
24 h post-treatment), thus demonstrating generalizability of endpoint determination across models (part 2). 
This is an Open Access article distributed under the terms of the Creative Commons 
Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution and reproduction in any medium, provi-
ded the original work is appropriately cited. 
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databases for all research articles from 1946 to Feb 07, 2018 us-
ing the following Boolean string with Medical Subject Head-
ings (MeSH): ((“Mice”[Mesh]) AND (“Endpoint Determina-
tion”[Mesh] OR “Animal Use Alternatives”[Mesh] OR humane 
endpoint* OR humane end point* OR surrogate endpoint* OR 
surrogate end point* OR thermometry OR thermometer OR te-
lemetry OR refinement OR welfare) AND (“Body Weight”[Mesh] 
OR “Body Temperature”[Mesh] OR body temperature OR weight 
NOT fetal NOT fetus OR score* OR scoring)), and on the Em-
base database for all research articles from 1947 to Feb 07, 2018 
using EMBASE Thesaurus (EMTREE) with Boolean string: (exp 
mice) and (exp Body Temperature or exp Body Weight or (score$ 
or scoring) or body temperature or (weight not fetal not fetus)) and 
(humane end point$ or humane endpoint$ or surrogate end point$ 
or surrogate endpoint$ or (thermometry or thermometer or telem-
etry) or (welfare or refinement)). 
2.1.2  Exclusion and inclusion criteria
Studies that fulfilled the following inclusion criteria were in-
cluded in the systematic review: (a) original research articles on 
mouse models of acute and/or chronic disease, (b) physiological 
parameters such as body temperature, body weight, or sickness 
severity scores were used individually or in combination to iden-
tify and/or evaluate humane endpoints, and (c) studies that ap-
plied pre-defined humane endpoints determined from body tem-
perature, body weight, or sickness severity scores. 
Irrelevant studies were excluded if: (a) subjects used were oth-
er than mice, (b) article was a conference abstract, experimen-
tal protocol, or review, (c) article was written in a language oth-
er than English, (d) parameters used to determine humane end-
points were other than body temperature, body weight, or sick-
ness severity scores, and (e) no humane endpoints were applied 
in the course of experiments or if the study was unrelated to hu-
mane endpoint determination.
2.1.3  Extraction of relevant data
Relevant data was extracted and compared through a data ex-
traction sheet. Extraction procedure was conducted by JM. Ex-
tracted data included (a) disease model, (b) sample size, (c) time 
course of the experiment, (d) frequency of evaluation/measure-
ment, (e) humane endpoint(s) used/proposed, (f) cut-off criteria 
for euthanasia, (g) metrics for evaluating the humane endpoint(s), 
and (h) performance of the humane endpoint(s). When multi-
ple endpoints were applied together in one study, all available 
descriptions were included. Missing data entries were marked 
with N/A (not applicable). 
2.2  Animal models of stroke and sepsis
2.2.1  Animals
No animals were used for this study. Rather, all data analyzed in 
this study were sourced from the authors’ previously published 
and unpublished results using a middle cerebral artery occlu-
sion (MCAo) stroke model and a lipopolysaccharide (LPS)-in-
duced systemic inflammation model, respectively (Hoffmann et 
al., 2015; Donath et al., 2016; Koch et al., 2017; Emmrich et al., 
tency in endpoint determination. However, the varying nature of 
animal models and disease progression, lack of reporting these 
details in the literature, lack of standardized evaluation protocols, 
and heterogeneity of endpoints published in the literature make 
it difficult to accurately determine and apply humane endpoints 
(Franco et al., 2012). 
So far, various approaches to humane endpoint evaluation have 
been proposed. These are based on physiological parameters such 
as body weight, temperature, or standardized sickness scores. 
Most commonly, analysis is conducted in a non-comprehensive 
manner, e.g., by arbitrary selection of a parameter and a cut-off 
value corresponding to the highest mortality rate or best separa-
tion between treated and sham-treated animals. However, these 
approaches often require manual, time-consuming computation 
and are prone to inter-observer bias. Machine learning, a tech-
nique used to identify underlying patterns from given datasets 
to produce reliable, repeatable predictions, has been applied in 
a number of different animal studies to classify individual/social 
behaviors (Kabra et al., 2013), automatize behavior analysis 
(Han et al., 2018), or to identify behavioral strategies and deci-
sion-making processes (Yamaguchi et al., 2018). To our knowl-
edge, using machine learning methods for humane endpoint 
characterization has not yet been systematically assessed.
The aim of the present study therefore was twofold: first, to 
identify and appraise existing humane endpoint definitions in 
mouse models of acute and chronic disease by conducting a sys-
tematic review of studies using weight, body temperature, and/or 
sickness scores for humane endpoint refinement and evaluation, 
and second, to examine the potential usefulness and accuracy of 
using machine learning with an automated parameter search to 
automatically define humane endpoints. To maximize generaliz-
ability of results, we used previously published and unpublished 
data from two independent mouse models of acute disease, 
namely, a middle cerebral artery occlusion (MCAo) stroke mod-
el and a lipopolysaccharide (LPS)-induced systemic inflamma-
tion model, respectively (Donath et al., 2016; Mei et al., 2018). 
We found great heterogeneity of published cut-off criteria and 
thresholds, illustrating a distinct difficulty in adopting humane 
endpoints from the literature. However, we show that machine 
learning can be used to accurately determine humane endpoint 
criteria and cut-off threshold values at early time points follow-
ing stroke or systemic inflammation thus potentially reducing 
otherwise unnecessary suffering.
2  Animals, materials, and methods
2.1  Systematic review
2.1.1  Search strategy
Studies were identified, screened and extracted for relevant da-
ta following the PRISMA (Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses) guidelines (http://www. 
prisma-statement.org). Literature search, title and abstract screen -
ing was conducted by JM. Full text screening was conducted by 
JM and JVE. A search was conducted on the MEDLINE/PubMed 
Mei et al.
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1 http://www.graphpad.com/quickcalcs/randomize1.cfm
2 https://www.randomizer.org
2017; Mei et al., 2018). For the original studies, all experimen-
tal procedures were approved by the ethical review committee 
of Landesamt für Gesundheit und Soziales (LaGeSo), 
Berlin (Reg G0385/08, G0188/11, G0354/11, G0197/12, G005/16, 
G0057/16, G0119/16, GG254/16, G0157/17, stroke; Reg G239/ 
15, sepsis) and were conducted in accordance with the German 
animal protection law and local animal welfare guidelines. Re-
porting of results based on the authors’ own historical data com-
plies with the ARRIVE guidelines (Kilkenny et al., 2010) and 
with the guidelines for genetically modified organisms (441/06). 
Data from 922 animals were included in this study. All inspec-
tions and measurements were performed in the same facility 
where animals were housed.
For the stroke model, adult male and female mice were used 
(total: n = 487; Tab. 1a; Slezak et al., 2007; Skarnes et al., 2011; 
Benedito et al., 2009; Glerup et al., 2014). Seven mice were not 
assigned to any treatment group (male: 5; female: 2) as they died 
of natural causes or reached a humane endpoint prior to the start 
of the experiment. Therefore, 480 out of 487 mice were random-
ly assigned to a 30 min MCAo (n = 73; male: 53; female: 20), a 
45 min MCAo (n = 331; male: 213, female: 118) or a sham proce-
dure (n = 76; male: 44; female: 32), at the age of 8-12 weeks. Mice 
were housed in groups of up to 12 animals per cage at 22 ±2°C, 
humidity of 55 ±10%, and a 12-hour light/dark cycle (12:12 h, 
lights on: 7:00 h, lights off: 19:00 h). Aspen woodchips were used 
as bedding.
For the sepsis model, female homozygous knockout mice and 
their homozygous wildtype littermates were used in experiments 
at the age of 8-10 weeks (total: n = 435; Tab. 1b). Mice were 
housed in groups of up to 12 animals per cage at 23 ± 1°C, hu-
midity of 60 ± 5%, and a 12-hour light/dark cycle (12:12 h light/
dark cycle, lights on: 20:00, lights off: 8:00) and were exposed to 
white noise at moderate intensity (65dB) during the dark phase 
(Dohm Sleepmate, Marpac Sound Machines, Wilmington, USA). 
During acute illness and recovery, mice were housed individual-
ly. Wood shavings were used as bedding.
2.2.2 Treatments 
Stroke model: Mice were subjected to 30 or 45 minutes temporary 
filamentous middle cerebral artery occlusion (MCAo) or sham 
procedure. The filamentous MCAo model was performed as de-
scribed in Dirnagl et al. (2012). For sham animals, the filament 
was advanced to the MCA and withdrawn immediately.
Sepsis model: Lipopolysaccharide (LPS) or physiological phos-
phate-buffered saline solution (PBS) were administered intraperi-
toneally for the induction of a systemic inflammatory response or 
control, respectively. The injection was performed as previously 
described (Mei et al., 2018).
Animals were randomized to treatment groups using the 
GraphPad calculator tool1 or Research Randomizer tool2 for the 
stroke and sepsis model, respectively. To minimize experimenter 
bias, randomization was conducted by a researcher who was not 
Tab. 1: Strain and origin of animals used for automated parameter search to define humane endpoints for (A) middle  
cerebral artery occlusion (MCAo) stroke model, and (B) lipopolysaccharide (LPS)-induced sepsis model 
m, male; f, female
A 
Strain n Origin
C57BL/6NCrl 74 (m: 74) Charles River Laboratories
Tg(Gjb6-cre/ERT2)53-33Fwp [MGI:4420273] x custom- 166 (m: 85; f: 81)  F. Pfrieger; Charité Universitätsmedizin Berlin; Research 
made Tg(ROSA26-FLEX IL6)1Ch  Institutes for Experimental Medicine 
C57BL/6N-Zfp580tm1a(EUCOMM)Hmgu/BayMmucd 158 (m: 84; f: 74) Charité Universitätsmedizin Berlin; Research Institutes for  
  Experimental Medicine
Tg(Cdh5-cre/ERT2)1Rha x custom-made 33 (m: 16; f: 17) R. Adams; Charité Universitätsmedizin Berlin; Research 
Tg(ROSA26-FLEX IL6)1Ch  Institutes for Experimental Medicine
Sorcs2tm1Anyk [MGI:5649357] 56 (m: 56) 
B
Strain n Origin
C57BL/6J 55 (f) Charles River Laboratories
Mertk (B6;129-Mertktm1Grl/J ) 126 (f) The Jackson Laboratory
Cd11b (B6;129-Mertktm1Grl/J, B6.129S4-Itgamtm1Myd/J) 126 (f) Hertie Institute for Clinical Brain Research
Mfge8 128 (f) C. Théry, INSERM 932, France
Mei et al.
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2.2.5  Humane endpoint criteria
In the stroke model, animals were euthanized by cervical disloca-
tion upon reaching a score of 2 of the 2nd criteria, or a score of 
3 or 4 of the 3rd-12th criteria in the modified DeSimoni neuroscore 
(Donath et al., 2016). In addition to the score-based criteria, ani-
mals were euthanized when a loss of more than 20% baseline body 
weight occurred or the following qualitative humane endpoint cri-
teria were observed during inspection: complete paralysis with ab-
sence of spontaneous movement, severe ataxia or loss of postur-
al reflexes, severe epileptic seizures, severe reduction of general 
health status with reduced grooming or refusal of food intake. 
In the sepsis model, upon reaching a sickness score greater 
than 4 once or a score of 4 twice within 2 hours, animals were im-
mediately removed from the cage and euthanized by cervical dis-
location (Mei et al., 2018).
2.2.6  Exclusion criteria
In the stroke model, animals that were (a) attacked by littermates 
before or during the experiment (n = 8); (b) failed to learn the be-
havioral task prior to MCAo (n = 9); (c) died during or within the 
first hour after anesthesia as a result of surgical complications (n 
= 12); (d) euthanized on the day of surgery (n = 1); (e) euthanized 
after the 30th day post-MCAo (n = 7); and (f) of a baseline tem-
perature < 32°C (n = 4), were not included in subsequent analy-
sis, leading to exclusion of 41 out of 487 animals (8.4%).
In the sepsis model, no animal was excluded.
2.2.7  Data analysis and statistics
Results are expressed as mean (SD) unless otherwise specified. Da-
ta processing and statistical analysis was performed using SPSS 
version 24 (SPSS Inc., Chicago, IL, USA) and Python 2.7.10 
(Python Software Foundation, Beaverton, OR, USA). Risk of death 
as an outcome event was evaluated with the scikit-learn toolkit 
(sklearn; Pedregosa et al., 2011) for physiological parameters includ-
ing core body temperature, surface body temperature, body weight 
and modified DeSimoni neuroscore or sickness severity score.
A primary aim of this study was to identify physiological pa-
rameters that can be used to separate animals that are at a high-
er risk of death from animals that would reach the planned ex-
perimental endpoint. Therefore, apart from assessing the predic-
tion accuracy of various models, we also identified the predictive 
power of physiological parameters, individually or in combina-
tion. To assess and identify (a) general performance of machine 
learning models, (b) usability of physiological parameters ob-
tained at different time points in death prediction, and (c) mod-
el hyperparameters, grid search with stratified 3-fold cross-val-
idation was applied. Core temperature (stroke model), surface 
temperature (sepsis model), body weight (both models), sickness 
score (sepsis model) or modified DeSimoni neuroscore (stroke 
model), and the absolute change of these parameters per time-
point (calculated by subtracting the baseline value from the mea-
sured value at a given timepoint) were used individually or in 
combination to train machine learning models. Models used for 
this study included logistic regression, Gaussian Naïve Bayes, 
decision tree (of max_depth = 1, 2, 3, or 4), support vector ma-
chine (with linear or radial basis function (RBF) kernels; C = 1, 
involved in injections, treatments, data acquisition or analysis. In-
formation on strain, genotype and treatment group assignment 
was concealed from experimenters until the end of the study.
 
2.2.3  Physiological parameters and scoring
In the stroke model, body weight and a modified version of the 
DeSimoni neuroscore, a composite score of general behavior-
al alterations and focal motor, sensory, reflex, and balance defi-
cits to evaluate neurological outcome following cerebral isch-
emia in mice, were obtained as previously described (Donath et 
al., 2016). Core body temperature was quantified non-invasively 
using subcutaneous radio-frequency identification (RFID) tran-
sponders as described (Donath et al., 2016). 
In the sepsis model, a sickness score adapted from the murine 
sepsis score was obtained based on general activity and response 
to stimuli as previously described (Mei et al., 2018). Surface 
body temperature was quantified using two non-contact infrared 
thermometer models as described previously (Mei et al., 2018). 
For body weight acquisition, a bench scale (PCB 1000-1, KERN 
& SOHN GmbH, Balingen, Germany) was used. Animals were 
weighed once their body and tail were in a plastic box placed on 
the top of the scale. 
In both disease models, the duration of manual handling was 
minimized to reduce stress and discomfort when examining 
signs of sickness of experimental animals. Low anxiety handling 
methods including cupping the animal between both hands and 
using a handling box were applied. In addition, and only if nec-
essary, animals were lifted by the base of the tail for no longer 
than 2-3 seconds.
2.2.4  Timeline of physiological monitoring
In the stroke model, baseline body weight and temperature were 
measured at 7:00-8:00 on the day of MCAo, followed by 2 in-
spections on the day of surgery and consequent daily inspection 
for qualitative humane endpoint criteria at 7:00-9:00 until day 28. 
The modified DeSimoni score for individual animals was assessed 
on the day of MCAo and on the 1st, 2nd, 7th, 14th, and 21st day 
post-MCAo as previously described (Donath et al., 2016). 
In the sepsis model, baseline temperature and weight were 
measured at 8:00 on the day of the first injection. Body tempera-
ture and sickness score were obtained eight times daily (8:00 to 
20:00, every 90 min) on the two consecutive injection days, then 
three times daily (8:00 to 20:00, every 6 h) for two days after the 
second injection, and once a day (8:00) from post-injection day 
3 until day 30 after the second injection. Body weight was ob-
tained three times daily (8:00 to 20:00, every 6 h) during the two 
injection days and the first two days following the second injec-
tion, then once per day at 8:00 until day 30 after the second in-
jection (Mei et al., 2018). To avoid stress-induced fluctuations in 
body temperature, animals were weighed after body temperature 
acquisition. 
Body temperature, body weight, and sickness score were as-
sessed for 21 or 30 days post-MCAo or LPS/PBS injection, re-
spectively. In accordance with the aim of the study, data from 
time points later than that of the death of the last animal in each 
experiment was not included. 
Mei et al.
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3  Results
3.1  Systematic review
1,578 search results were retrieved (Medline: 668; Embase: 910) 
and 1,238 were included in title and abstract screening after dupli-
cates were removed. Overall, 110 full text articles were screened 
and a total of 34 studies were included for subsequent data ex-
traction (Fig. 1; Tab. 2). Included studies represented a wide range 
of acute and chronic mouse models including infection/inflamma-
tion (n = 14; Nemzek et al., 2004; Huet et al., 2013; Bast et al., 
2004; Adamson et al., 2013; Kort et al., 1998; Hankenson et al., 
2013; Warn et al., 2003; Arranz-Solis et al., 2015; Dellavalle et al., 
2014; Molins et al., 2012; Wright and Phillpotts, 1998; Sand et al., 
2015; Miller et al., 2013; Trammell and Toth, 2011), toxin/poison-
ing (n = 3; Vlach et al., 2000; Beyer et al., 2009; Cates et al., 2014), 
cancer/tumor (n = 5; Husmann et al., 2015; Aldred et al., 2002; 
Miller et al., 2016; Paster et al., 2009; Hunter et al., 2014), and oth-
ers (n = 12; Solomon et al., 2011; Stoica et al., 2016; Leon et al., 
2005; Takayama-Ito et al., 2017; Passman et al., 2015; Chappell 
et al., 2011, Faller et al., 2015; Weismann et al., 2015; Koch et al., 
2016; Nunamaker et al., 2013a,b; Ray et al., 2010). 
10, or 100; gamma = 0.01, 0.001, or 0.0001), and random forest 
classifier (with n_estimators = 2, 4, or 8). 
Available data from all time points before the average time of 
death of non-survivor animals was included in the analysis. First, 
to reduce complexity of the analysis and enhance the applicabil-
ity of the method, measurements obtained at the same time point 
were used to train the predictive models. For example, tempera-
ture readings obtained at 24 hours after stroke/sepsis could be 
combined with sickness scores obtained at the same time point, 
but not sickness scores obtained at other time points. Second, 
an expanded parameter search with combinations of physiolog-
ical parameters obtained at different time points was conduct-
ed. When training support vector machines, input features were 
scaled to a zero mean and unit variance. 
2.2.8  Data availability
Two datasets including (1) core body temperature, body weight, 
and modified DeSimoni neuroscore of animals of the stroke 
model3 and (2) surface body temperature, body weight and sick-
ness severity score of animals of the sepsis model4 are available 
as open data on Figshare Repository in raw data format.
3 doi:10.6084/m9.figshare.7479965
4 doi:10.6084/m9.figshare.7480016
Fig. 1: Flow 
diagram showing 




included in this 
systematic review
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Tab. 2: List of studies included in the review (n = 34) summarized by type of experiment, sample size, time course  
of the experiment, type of humane endpoints, frequency of inspection/measurement, and cut-off threshold used/proposed  
for euthanasia  
N/A, not found/not available; sur, survived
Experiment Sample size Time course Type of humane Frequency of Cut-off threshold Reference 
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al., 2014; Aldred et al., 2002; Husmann et al., 2015). In two stud-
ies (Adamson et al., 2013; Trammell and Toth, 2011), individual 
physiological parameters were assessed at different time points. 
In three studies, animals were inspected only once after treatment 
(Takayama-Ito et al., 2017; Sand et al., 2015; Faller et al., 2015). 
3.1.2  Body temperature 
Among the 34 studies, 14 demonstrated that both core body tem-
perature (n = 10; Molins et al., 2012; Leon et al., 2005; Beyer 
et al., 2009; Cates et al., 2014; Hankenson et al., 2013; Tram-
mell and Toth, 2011; Warn et al., 2003; Kort et al., 1998; Vlach 
et al., 2000; Ray et al., 2010) and surface body temperature 
(n = 4; Adamson et al., 2013; Bast et al., 2004; Nemzek et al., 
2004; Dellavalle et al., 2014) could be used to refine the hu-
mane endpoint. In 6 of the 14 studies, other physiological pa-
rameters were used in combination or independently as humane 
endpoint criteria, including clinical signs (Beyer et al., 2009), 
weight (Hankenson et al., 2013; Adamson et al., 2013; Nemzek 
et al., 2004), and the product of body temperature and weight 
(Trammell and Toth, 2011; Ray et al., 2010). Cut-off values for 
euthanasia ranged from 23.4 to 36°C (31.55 (4.7) °C) for end-
points determined from core temperature and from 28.8 to 30°C 
(29.7 (0.6) °C) for endpoints determined from surface tempera-
ture. In addition, recovery from hypothermia (Leon et al., 2005) 
or a temperature drop below the baseline mean temperature (Mo-
lins et al., 2012) were used as humane endpoints. While in most 
studies, animals were humanely killed upon reaching the cut-off 
criterion at one single time point, Beyer et al. (2009) euthanized 
animals when the body temperature was lower than 32°C in two 
consecutive inspections. 
3.1.3  Body weight 
In 14 out of the 34 studies, body weight was used to determine 
the humane endpoint (Takayama-Ito et al., 2017; Passman et al., 
2015; Miller, D. S. et al., 2013; Miller, A. et al., 2016; Faller et 
al., 2015; Weismann et al., 2015; Adamson et al., 2013; Hanken-
son et al., 2013; Trammell and Toth, 2011; Nemzek et al., 2004; 
Stoica et al., 2016; Husmann et al., 2015; Ray et al., 2010; Hunt-
er et al., 2014). All of these 14 studies included additional hu-
3.1.1  Time course of the study and frequency  
of monitoring
Time courses of experiments ranged from 8 hours to 40 months. 
Among the 34 studies, duration of experiments was shorter than 
or equal to 24 hours in 2 studies (Kort et al., 1998; Cates et al., 
2014), between a day and a week in 5 studies (Leon et al., 2005; 
Beyer et al., 2009; Miller et al., 2013; Bast et al., 2004; Huet et 
al., 2013), between a week and one month in 17 studies (Mo-
lins et al., 2012; Takayama-Ito et al., 2017; Passman et al., 2015; 
Wright and Phillpotts, 1998; Sand et al., 2015; Chappell et al., 
2011; Adamson et al., 2013; Koch et al., 2016; Trammell and 
Toth, 2011; Nunamaker et al., 2013a,b; Nemzek et al., 2004; 
Dellavalle et al., 2014; Aldred et al., 2002; Warn et al., 2003; 
Vlach et al., 2000; Arranz-Solis et al., 2015), between one month 
and 3 months in 6 studies (Miller et al., 2016; Faller et al., 2015; 
Hankenson et al., 2013; Paster et al., 2009; Husmann et al., 
2015; Hunter et al., 2014), and longer than 3 months in 4 studies 
(Weismann et al., 2015; Solomon et al., 2011; Stoica et al., 2016; 
Ray et al., 2010). 
A great variance was observed in the frequency of evaluation 
intervals, with the most frequent data collection occurring once 
per minute using an automated system (Leon et al., 2005), while 
the longest interval between inspections was once or at least once 
every 4 weeks (Ray et al., 2010; Weismann et al., 2015). Some 
authors used an inspection frequency of once per day (Miller, D. 
S. et al., 2013; Miller, A. et al., 2016; Chappell et al., 2011; Pas-
ter et al., 2009; Nemzek et al., 2004), while others used varying 
interval frequencies such as once per 15 minutes (Vlach et al., 
2000), once per 30 minutes (Beyer et al., 2009), twice per day 
(Cates et al., 2014; Kort et al., 1998; Arranz-Solis et al., 2015), at 
least twice per day (Wright and Phillpotts, 1998), at least 4 times 
per day (Warn et al., 2003), once per week (Stoica et al., 2016), 
5-7 times per week (Hunter et al., 2014). As expected, in studies 
with faster disease progression, authors adjusted the evaluation 
schedule accordingly by increasing the frequency of monitor-
ing for animals in severe distress or animals requiring addition-
al care (Molins et al., 2012; Passman et al., 2015; Hankenson et 
al., 2013; Huet et al., 2013; Koch et al., 2016; Trammell and Toth, 
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cy. For example, the composite obtained by multiplying weight 
and body temperature yielded higher prediction accuracy than ap-
plying weight or body temperature cut-off criteria individually.
3.1.6  Evaluation of the humane endpoints
Twenty studies assessed the performance of humane endpoints. 
Predictability of death as an outcome event was evaluated by 
means of sensitivity (n = 6, min = 68%, max = 100%, mean (SD) 
= 89.7 (13.1)%; Adamson et al., 2013; Hankenson et al., 2013; 
Trammell and Toth, 2011; Dellavalle et al., 2014; Kort et al., 1998; 
Warn et al., 2003), specificity (n = 3, min = 90.9%, max = 100%, 
mean (SD) = 96.0 (4.6)%; Adamson et al., 2013; Hankenson et al., 
2013; Warn et al., 2003), logistic regression (n = 2, p < 0.0001 and 
p = 0.0077; Cates et al., 2014; Vlach et al., 2000), prediction accu-
racy (n = 2, 92.7% and 2% underestimation; Koch et al., 2016; Ray 
et al., 2010), percentage/number of mice present with a particular 
criterion/sign (n = 5, min = 86%, max = 100%, mean (SD) = 95.3% 
(5.8); Molins et al., 2012; Takayama-Ito et al., 2017; Bast et al., 
2004; Solomon et al., 2011; Aldred et al., 2002), relative number 
of predicted dead animals (n = 1, 96%; Vlach et al., 2000), phys-
iological changes observed in different treatment groups (n = 2, 
significant difference observed; Paster et al., 2009; Leon et al., 
2005), positive predictive value (n = 1, 55.5%; Nemzek et al., 
2004), false positive rate (n = 1, 4-33%; Trammell and Toth, 
2011), and corresponding mortality rate (n = 2, 86.2-100% and 
78.6-100%; Nunamaker et al., 2013a,b) with some studies using 
multiple evaluation metrics. In one study, specificity was used to 
assess humane endpoint performance. However, it could not be 
appropriately assessed as none of the animals reached the pre-de-
fined cut-off criterion (Dellavalle et al., 2014).
3.2  Death prediction in animal 
models of stroke and sepsis
To facilitate direct comparison, animals in both stroke and sep-
sis models were divided into three groups based on treatment and 
survival. Group 1 (control, n(stroke) = 66, n(sepsis) = 151) con-
sisted of sham animals or animals treated with saline that reached 
the planned experimental endpoint, group 2 (survivor group, 
n(stroke) = 322, n(sepsis) = 254) consisted of animals treated 
with MCAo or LPS that reached the planned experimental end-
point and group 3 (non-survivor group, n(stroke) = 58, n(sepsis) 
= 30) consisted of animals that spontaneously died or were eutha-
nized upon reaching the humane endpoint criteria.
3.2.1  Body temperature in survivor and  
non-survivor animals
In the stroke model, the temperature of the survivor and non-sur-
vivor groups decreased by an average of 1.1°C and 4.6°C from 
baseline (35.3 (2.1) °C and 31.6 (6.6) °C, respectively) during 
the first 5 days following MCAo (Tab. 3). The core body 
temperature of the control group remained unchanged during the 
experiment.
In the sepsis model, LPS-treated animals showed a pronounced 
decrease in surface body temperature during the two consecutive 
injection days, regardless of survival status. Lowest surface tem-
perature of survivor animals was observed 10.5 hours following 
mane endpoints such as clinical signs of distress and disease pro-
gression (Miller et al., 2016; Faller et al., 2015; Weismann et al., 
2015; Stoica et al., 2016; Husmann et al., 2015; Hunter et al., 
2014), sickness severity scores (Passman et al., 2015; Miller et 
al., 2013; Takayama-Ito et al., 2017), body temperature (Han-
kenson et al., 2013; Adamson et al., 2013; Nemzek et al., 2004), 
and the product of body temperature and weight (Trammell and 
Toth, 2011; Ray et al., 2010). Although a weight loss of more 
than 20% compared to baseline is widely regarded as a common 
humane endpoint, it was only reported in 3 studies (Passman et 
al., 2015; Adamson et al., 2013; Ray et al., 2010). Other authors 
used a weight loss of more than 15% (Takayama-Ito et al., 2017; 
Miller et al., 2016; Weismann et al., 2015; Stoica et al., 2016; 
Husmann et al., 2015) or 25% (Miller et al., 2013). One study 
used an absolute weight loss of greater than 0.05 g per day as an 
indicator of a higher risk of death (Hankenson et al., 2013). In a 
mouse model of cecal ligation and puncture (CLP), initial weight 
gain was observed in 100% animals that died within the next 3 
days and was therefore considered as an indicator of higher risk 
of death (Nemzek et al., 2004). One study did not define a cut-
off threshold for a weight-based humane endpoint (Faller et al., 
2015). Another used the product of body temperature and weight 
for humane endpoint definition (Trammell and Toth, 2011). 
3.1.4  Sickness severity score 
Among 15 studies that used sickness severity scores to deter-
mine the humane endpoint (Passman et al., 2015; Wright and 
Phillpotts, 1998; Sand et al., 2015; Miller et al., 2013; Chappell 
et al., 2011; Huet et al., 2013; Koch et al., 2016; Nunamaker et 
al., 2013a,b; Paster et al., 2009; Solomon et al., 2011; Arranz-So-
lis et al., 2015; Aldred et al., 2002; Hankenson et al., 2013; 
Takayama-Ito et al., 2017), 3 applied the score-based threshold 
with other criteria such as weight (Passman et al., 2015; Miller et 
al., 2013; Takayama-Ito et al., 2017) and clinical signs (Paster et 
al., 2009). There was great heterogeneity in score-based thresh-
olds, reflecting the common use of model-specific scores. In 12 
studies higher scores indicated more severe symptoms. In one 
study, a score of 0-1 was assigned to animals showing abnormal 
behavior and appearance, using a total score of 1 as the humane 
endpoint (Paster et al., 2009). In one study, a score sheet indicat-
ing clinical symptoms was used to determine sickness severity, 
however, the cut-off value for early euthanasia was not clearly 
described (Aldred et al., 2002). 
3.1.5  Combining body weight, body 
temperature, and sickness severity scores 
in humane endpoint determination
In 16 studies, more than one physiological or behavioral parame-
ter was used in determining the humane endpoint. Thus, the cut-
off criterion was defined by fulfilling one or more physiological 
or behavioral criteria. Among the 15 studies, 3 studies involved a 
direct combination (e.g., the product of two parameters) of more 
than one physiological parameter to derive a surrogate indicator 
for a higher risk of death (Hankenson et al., 2013; Trammell and 
Toth, 2011; Ray et al., 2010). In studies using a product of more 
than one parameter, death could be predicted with higher accura-
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4th day following MCAo. Once the minimum was reached, all 
groups subsequently recovered body weight until the end of the 
observation period. 
In the sepsis model, no weight changes other than random fluc-
tuations were observed in control animals. Body weight of the sur-
vivor group reached its minimum 54 hours following the first LPS 
injection (17.7 (1.5) g) and returned to baseline at 192 hours (21.7 
(1.6) g, as compared to baseline weight = 21.5 (1.8) g). The low-
est weight of non-survivor animals (baseline weight: 21.4 (2.0) g) 
was measured 96 hours after the first injection (14.4 (2.4) g). 
3.2.3  Sickness severity score in survivor and  
non-survivor animals
In the stroke model, modified DeSimoni neuroscore of control 
animals was 0.9 (1.0) at baseline, peaked at 5.7 (4.3) on the 1st 
day after MCAo and subsequently decreased on the 2nd day af-
ter MCAo (Tab. 3). Non-survivors had a higher score on the 1st 
and 2nd day following MCAo than survivors (16.0 (9.6) and 14.8 
(9.4) vs. 9.2 (5.2) and 9.1 (5.7), respectively). 
both the first and second injections (27.4 (1.7) °C and 28.1 (1.6) °C, 
respectively). The surface body temperature of the survivor 
group returned to baseline within 96 hours following the second 
LPS injection. Surface temperature of non-survivor animals was 
the lowest 10.5 hours following the first injection (25.4 (1.8) °C) 
and 9 hours following the second injection (23.4 (1.2) °C), re-
spectively. No significant decrease in core and surface tempera-
tures from baseline was observed in control animals. 
3.2.2  Body weight in survivor and non-survivor  
animals
In the stroke model, a decrease in body weight was observed 
in control animals, survivors and non-survivors (Tab. 3). In the 
control group, body weight was 24.8 (3.2) g at baseline decreas-
ing to a minimum of 22.3 (2.5) g on the 2nd day post-treatment. 
The lowest weight of survivor animals 21.0 (2.8) g was mea-
sured on the 2nd day following MCAo. The non-survivor group 
had the most profound decrease of 8.0 g from baseline (26.9 
(3.7) g). The lowest mean body weight was 18.9 (2.6) g on the 
Tab. 3: Comparison of physiological measures among control, survivor and non-survivor groups  
(A) Middle cerebral artery occlusion (MCAo) stroke model, from the day animals underwent the MCAo procedure up to the 5th day 
post stroke; (B) lipopolysaccharide (LPS)-induced sepsis model, from the first injection up to 192 h after the first injection. Baseline 
measurements were conducted before the MCAo/sham treatment or the first LPS/saline injection. Baseline values were measured on  
the day of treatment. Monitoring period was defined as the 1st to 5th day post-stroke and the 1st to 8th day post-sepsis.
A
 Control (n = 66) Survivor (n = 322) Non-survivor (n = 58)
Baseline core temperature (°C)  35.7, 38.9 34.1, 38.9 28.0, 38.3 
min, max, mean (SD) 37.0 (0.8) 36.4 (1.0) 36.2 (1.9)
Core temperature during monitoring (°C) 33.7, 38.4 20.8, 38.4 17.8, 37.8 
min, max, mean (SD) 36.6 (0.9) 35.7 (1.6) 33.5 (3.7)
Baseline body weight (g) 16.0, 32.6 16.7, 34.9 14.5, 33.9 
min, max, mean (SD) 24.8 (3.2) 25.4 (3.3) 26.9 (3.7)
Body weight during monitoring (g) 16.1, 30.1 13.9, 31.0 14.3, 29.6 
min, max, mean (SD) 22.4 (2.4) 21.4 (3.0) 21.0 (3.1)
Baseline Neuroscore 0, 3 0, 4 0, 2 
min, max, mean (SD) 0.9 (1.0) 0.33 (0.8) 0.4 (0.9)
Neuroscore during monitoring 0, 17.0 0, 35 0, 41 
min, max, mean (SD) 4.9 (4.9) 9.1 (5.5) 15.4 (9.5)
B
 Control (n = 151) Survivor (n = 254) Non-survivor (n = 30)
Baseline surface temperature (°C) 27.0, 33.7 26.3, 33.8 27.5, 33.3 
min, max, mean (SD) 30.8 (1.1) 30.5 (1.6) 30.6 (1.4)
Surface temperature during monitoring (°C) 23.9, 36.5 20.3, 34.6 19.0, 31.7 
min, max, mean (SD) 30.6 (1.4) 29.1 (2.0) 25.7 (2.7)
Baseline body weight (g) 17.5, 26.9  14.9, 28.7 17.6, 24.3 
min, max, mean (SD) 21.5 (1.7) 21.5 (1.8) 21.4 (2.0)
Body weight during monitoring (g) 16.4, 27.6 13.2, 27.7 12.5, 23.3 
min, max, mean (SD) 21.9 (1.5) 19.7 (2.1) 18.8 (2.6)
Sickness score during monitoring 0, 2 0, 4 0, 4.5 
min, max, mean (SD) 0 (0.1) 0.7 (0.8) 2.1 (1.1)
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nations of parameters. Apart from body weight, temperature, and 
sickness score/neuroscore, the absolute change per timepoint for 
these parameters was calculated by subtracting the baseline value 
from measured values at each timepoint, resulting in an addition-
al parameter set. The two sets of parameters were used in model 
training. 
Machine learning models were trained with individual param-
eters or combinations of physiological and behavioral parame-
ters. Model performance was analyzed for time points prior to 
the average time of death (i.e., 3.9 (2.4) days in the stroke model 
and 60.5 (35.1) hours in the sepsis model, respectively). Animals 
in the stroke model displayed a significant gender-dependent dif-
ference in baseline body weight (male: 26.8 (2.8) g; female: 23.1 
(2.9) g; p < 0.001, Mann-Whitney U test), thus death prediction 
was conducted separately for each gender.
In the sepsis model, sickness scores of the survivor group peak-
ed at 10.5 hours (1.2 (0.8)) and 12 hours (1.4 (0.9)) after the in-
jection on day 1 and 2, respectively, then returned to baseline 
level within 96 hours following the first LPS injection. Sickness 
scores of non-survivors increased after injection day 1 and peak-
ed at 10.5 hours after the second injection (3.3 (0.6)). The sick-
ness scores among control animals remained unchanged (Tab. 3).
3.2.4  Prediction of death from physiological  
measures 
To assess the performance of physiological and behavioral pa-
rameters such as body weight, temperature, and sickness severity 
score/modified DeSimoni neuroscore in death prediction, we de-
veloped an automated parameter search method to test the perfor-
mance of machine learning models trained with different combi-
Fig. 2: Decision boundaries determined by the machine learning model
The earliest time points (2 and 3 days or 24 h post-treatment in the stroke or sepsis model, respectively) at which impending death could  
be predicted with acceptable accuracy were included. Data from 36 h post-injection in the sepsis model was plotted for comparison 
purposes. Parameter-model combinations leading to highest prediction accuracy were plotted. (a) Decision boundary obtained with 
body weight change on the 1st and 3rd day after treatment and core body temperature change on the 3rd day after treatment. (b) Decision 
boundary obtained with the modified DeSimoni neuroscore, body weight change and core body temperature change on the 2nd day  
after treatment. (c) Decision boundary obtained with surface temperature and sickness score 24 h after the first injection of LPS/saline.  
(d) Decision boundary obtained with surface temperature and sickness score 36 h after the first injection. Blue dot, survivor animal (control 
+ survivor); red dot, animal euthanized upon reaching the pre-defined sickness score-based humane endpoint or died spontaneously (non-
survivor); blue area, predicted survival; red area, predicted death. Gaussian Naïve Bayes (as in a and b), decision trees of depth 2 (as in c) 
and 1 (as in d) were used to determine the decision boundaries. 
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cision from 0.25 (0.20) to 0.83 (0.24) and accuracy from 0.86 
(0.045) to 0.93 (0.030) of the trained model. 
In the sepsis model, using both sickness score and surface tem-
perature in model training improved accuracy and general per-
formance of the prediction model (Tab. 4b). At 24 hours after 
treatment, using sickness score in addition to surface tempera-
ture in model training led to an increase in sensitivity from 0.65 
(0.11) to 0.86 (0.12) and accuracy from 0.95 (0.01) to 0.96 (0.01), 
while model precision decreased slightly from 0.77 (0.17) to 0.75 
(0.11). 
Interaction between the use of multiple physiological  
measurements and time points
In the stroke model, due to the low performance of models trained 
with combinations of physiological parameters obtained on the 
same day, data from different post-treatment days were used in 
combination in model training. This approach precluded the as-
sessment of an interaction between multiple parameters and indi-
vidual time points.
In the sepsis model, using multiple physiological parameters 
to train the predictive model enhanced the accuracy of death pre-
diction at individual time points. When the model was trained 
with data from 24 hours after the first LPS injection, using sick-
ness score as an additional measure increased sensitivity and 
accuracy by 21.5% and 1.1%, respectively (Tab. 4b). No im-
provement in model performance was observed using data from 
36 hours after the first LPS injection when sickness scores were 
included in model training (Tab. 4b). 
4  Discussion
Our study revealed three main findings: Firstly, the systematic 
review demonstrated remarkable heterogeneity of humane end-
points even within the same animal model due to lack of sys-
tematic assessment, protocol standardization, and/or ambiguous 
or incomplete description of results. This illustrates a distinct 
challenge in adopting humane endpoints from the literature and 
highlights the need for researchers to tailor humane endpoints 
based on the currently available evidence. Secondly, using data 
from mouse models of stroke and sepsis, we found that machine 
learning by means of an automated search for predictive parame-
ters, parameter combinations, and models and hyperparameters, 
can be used to accurately determine endpoint criteria and cut-off 
threshold values across models. Thirdly, when we applied these 
criteria retrospectively to the available derivation cohort data-
sets, we found that a large number of animals could have been 
euthanized at earlier time points in both stroke and sepsis mod-
els, thus potentially reducing otherwise unnecessary suffering. 
4.1  Systematic review
In this study, we reviewed 34 mouse studies using humane end-
points based on body temperature, body weight and/or sickness 
severity score (Tab. 5). We found that temperature-based end-
points are commonly applied both in acute and chronic disease 
Death as an outcome event could be predicted with consider-
able accuracy of 93.2% (male) or 93.0% (female) in the model of 
stroke and 96.2% in the model of sepsis (Tab. 4a,b), with weight 
change on the 1st and 3rd day after treatment, core temperature 
change on the 3rd day after treatment (male, stroke model), or with 
neuroscore, weight change, and core temperature change on the 
2nd day after treatment (female, stroke model), and with surface 
temperature and sickness score at 24 hours after the first injection 
(sepsis model). Gaussian Naïve Bayes (male and female, stroke 
model), decision tree of a depth of 2 (with data from 24 hours 
after the first injection, sepsis model) and 1 (with data from 
36 hours after the first injection, sepsis model) were used to iden-
tify decision boundaries shown in Figure 2.
In male mice of the stroke model, 13 out of 23 animals that 
died or reached predefined humane endpoint criteria at a later 
time point could have been euthanized earlier (t = 3 days after 
MCAo for euthanasia; average time of death of the 13 animals 
= 4.08 (1.07) days post-MCAo) while 3.3% (6 out of 181) sur-
vivors were falsely predicted to die. In female mice of the stroke 
model, 4 out of 10 animals that died or reached the predefined 
humane endpoint during the experiment could have been eutha-
nized earlier (t = 2 days after MCAo for euthanasia; average time 
of death of the 4 animals = 4.25 (2.28) days post-MCAo). 3.9% 
(3 out of 77) animals that survived until the end of the experiment 
were falsely predicted to die (Fig. 2a,b).
In the sepsis model, 25 out of 28 animals could have been eu-
thanized at an earlier time point (t = 24 hours post treatment for 
earlier euthanasia; average time of death of the 25 animals = 
58.7 (35.0) hours post treatment) while 2.3% (6 out of 254) of 
LPS-treated animals that survived until the end of the experiment 
were falsely predicted to die (Fig. 2c,d).
Prediction of death as an outcome event at different  
post-treatment time points
By applying machine learning models trained with physiological 
parameters, death could be predicted within 2 or 3 days (stroke 
model) or 24 hours (sepsis model) after MCAo or LPS injection. 
In the stroke model, death could not be predicted at an accept-
able level of accuracy until the 2nd (female mice) or 3rd (male 
mice) day post-MCAo (Tab. 4a). In the sepsis model, physiolog-
ical measures obtained 12 hours after the first injection could not 
predict death as an outcome event due to the low general perfor-
mance of the model at this time point (for details see Tab. 4b). 
Prediction of death by using single or multiple  
physiological measurements
In the stroke model, adding additional physiological parameters 
in model training increased death prediction performance (Tab. 
4a). In male mice, adding weight change on the 1st day after treat-
ment and core temperature change on the 3rd day after treatment 
increased sensitivity from 0.34 (0.15) to 0.61 (0.088), precision 
from 0.64 (0.27) to 0.74 (0.070), and accuracy from 0.91 (0.03) to 
0.93 (0.02). In female mice, using neuroscore and core tempera-
ture change on the 2nd day after treatment in addition to weight 
change improved sensitivity from 0.19 (0.14) to 0.69 (0.28), pre-
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temperature, while the animal’s core temperature stays constant 
as long as thermoregulatory responses are intact (Kurz, 2008). In 
addition, measurement location and handling stress may contrib-
ute to differences in cut-off values between studies. Some authors 
used restraining devices for probe-based surface temperature ac-
quisition. However, stress results in activation of the sympathet-
ic nervous system, which in turn leads to increased thermogene-
sis and vasoconstriction of skin vessels, resulting in an increase 
in body temperature within seconds of being restrained (Vianna 
and Carrive, 2005). Therefore, body temperature measurements 
could be confounded by repeated handling (Cabanac and Briese, 
1992). 
models due to their objectivity and ease of measurement. How-
ever, we found considerable variations in temperature cut-off val-
ues between studies even within the same animal model (Molins 
et al., 2012; Beyer et al., 2009; Adamson et al., 2013; Bast et al., 
2004; Cates et al., 2014; Hankenson et al., 2013; Trammell and 
Toth, 2011; Nemzek et al., 2004; Dellavalle et al., 2014; Hunter et 
al., 2014; Warn et al., 2003; Kort et al., 1998; Vlach et al., 2000; 
Ray et al., 2010), which can at least partly be explained by varia-
tions in ambient temperature. 
Ambient temperature is an important factor contributing to dif-
ferences between an animal’s core and surface temperature. The 
lower the ambient temperature, the lower an animal’s surface 
Tab. 4: Death prediction with single or multiple parameters at different time points  
(A) Middle cerebral artery occlusion (MCAo) stroke model. Prediction model, Gaussian Naïve Bayes. (B) Lipopolysaccharide (LPS)-induced 
sepsis model. Prediction model, decision tree with a depth = 2 (24 h) and a depth = 1 (36 h). Decision tree of depth 2 was not used for  
36 h after the first injection due to overfitting. 3-fold stratified cross-validation was used to evaluate the performance of the trained model. 
Only performance of the most predictive parameters and model combinations is shown. Data shown are means (SD) of scores obtained 
from the 2- (stroke model) or 3- (sepsis model) fold cross-validation.
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criteria) while sickness scores were mostly used independently 
(3 out of 13 studies used additional criteria). In 2 studies that eval-
uated the use of a composite score derived from other parameters 
(i.e., the product of weight x body temperature), a higher predic-
tion accuracy was observed than when assessing parameters in-
dividually (Trammell and Toth, 2011; Ray et al., 2010). Authors 
used various metrics to assess the performance of humane end-
points, which often precludes direct between-study comparison. 
The three most common metrics were sensitivity (n = 7), specific-
ity (n = 5), and percentage/number of mice exhibiting certain cri-
teria/signs (n = 5). In 12 out of the 34 studies, humane endpoints 
were applied without being evaluated for reliability and/or per-
formance or without endpoint evaluation being reported by the 
authors. Therefore, researchers may fail to appreciate the validity 
and/or reproducibility of humane endpoint criteria. 
Taken together, traditional approaches in monitoring disease 
progression and predicting death suffer from high degrees of 
study heterogeneity, which confounds identification of cut-off 
values that can be applied to more than one study. 
4.2  Machine learning-based death prediction
In an exploratory approach, we used machine learning as an al-
ternative method for determining humane endpoints, which en-
abled us to identify case-specific cut-off values even across ani-
mal models without a fundamental change in methodology. Us-
ing body weight, sickness severity scores, and surface or core 
temperature data (for the sepsis or stroke model, respectively) 
from previously published studies and unpublished results, we 
trained a machine learning model for case-specific death pre-
diction. First, we identified the parameter combinations that led 
to a high accuracy in detecting animals at higher risk of death. 
We then determined the cut-off values and assessed their perfor-
mance using standardized metrics. We found that 17 out of 33 
(stroke model) and 25 out of 28 (sepsis model) animals that were 
Humane endpoints based on rapid (over a few days) or gradu-
al (over extended periods of time leading to emaciation) weight 
loss relative to baseline are easy to adopt and are widely applied. 
However, weight-based endpoints are suboptimal in highly acute 
models of disease (i.e., circulatory shock) due to an animal’s rap-
id deterioration which may precede weight loss (Louie et al., 
1997; Krarup et al., 1999; Nemzek et al., 2004). In addition, true 
weight loss may be masked by debilitating conditions such as as-
cites or tumor growth (Nemzek et al., 2004).
Sickness severity scores serve as a simplified classification of 
the physiological state of an animal, allowing systematic docu-
mentation of disease progression and humane endpoint evalua-
tion. However, manual scoring suffers from subjectivity and is 
prone to high degrees of inter-observer bias (Morton, 2000). 
Another factor contributing to high study heterogeneity is the 
lack of standardized schedules for animal inspection. Even for 
identical animal models, authors rarely used measurement sched-
ules which were consistent with previously published data (Nun-
amaker et al., 2013a,b). Furthermore, only a minority of studies 
(9 out of 34) described the exact times relative to baseline and/or 
experimental intervention when temperature, body weight, and/
or sickness score values were taken. Other variables potentially 
adding to study heterogeneity but only described by few studies 
include environmental factors such as the presence and type of 
bedding (described in 17 out of 34 studies) and number of cage 
mates (described in 22 out of 34 studies; Gordon, 2004; Gordon 
et al., 1998), as well as animal-specific factors such as strain, gen-
otype, sex and developmental stage (described in all reviewed 
studies; Sanchez-Alavez et al., 2011; Trammell and Toth, 2011). 
To counter the uncertainty in endpoint evaluation caused 
by variation of individual parameters, 15 of the reviewed stud-
ies used a combination of more than one humane endpoint cri-
terion. Body weight was most commonly applied in combina-
tion with additional criteria (13 out of 13 studies used additional 
Tab. 5: Summary of endpoint criteria, advantages and disadvantages of weight-, body temperature-, and severity score-based 
humane endpoints
Humane endpoint Studies included Endpoint  Advantages Disadvantages
Weight-based 13 15-25% of baseline − easy administration − poor performance in 
  body weight − high objectivity − acute disease models 
    − high handling stress
Core  11 23.4-36°C, 31.55 (4.7) °C − high objectivity − high variance due to 
temperature-based   − high accuracy  − an animal’s thermo- 
   − continuous monitoring  − regulatory responses 
   − low handling stress − and handling stress
Surface 4 28.8-30°C, 29.7 (0.6) °C − high objectivity − high variance due to 
temperature-based   − high accuracy  − an animal’s thermo- 
   − low handling stress − regulatory responses  
    − and handling stress
Severity score-based 14 Multiple criteria − easy administration  − requires familiarity 
   − simplified classification  − inter-observer variability 
   − of physiological states  − time-consuming 
   − systematic  − high handling stress 
   − documentation 
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chine learning, we identified humane endpoints that would have 
allowed earlier euthanasia of animals, thus potentially reducing 
an animal’s distress, suffering, and pain. Although the method 
still requires further validation, this exploratory study showed 
that machine learning-based humane endpoint criteria have the 
potential to be applied across various disease models. This may 
contribute to a more comprehensive approach in determining 
humane endpoints promoting the systematic application of 3R 
principles.
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